Merve Sena Odabaşı
Merve Sena Odabaşı has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Melahat Dirican
Department of Medical Biochemistry, Faculty of Medicine Bursa Uludağ University Bursa Türkiye
2 shared publications Ş Ahin
Environmental Engineering, Istanbul University-Cerrahpasa, Istanbul, Turkey
1 shared publication- Adile Merve Baki
Istanbul Faculty of Medicine
1 shared publication - Ahmet Altin
Department of Environmental Engineering, Bulent Ecevit University, Zonguldak, Turkey
1 shared publication - Alpay Ari
Department of Infectious Diseases and Clinical Microbiology, Izmir Faculty of Medicine, University of Health Sciences, İzmir
1 shared publication - Arslan Saral
Department of Environmental Engineering Faculty of Civil Engineering Yildiz Technical University 34220 İstanbul Türkiye
1 shared publication
Latest Publications
- Open Access
- 22 October 2025
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 47, e00509
Can the icteric index be used instead of total bilirubin in addition to being a preanalytical marker? Icteric index in the laboratory
- 22 October 2025
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 47, e00509
Open AccessCan the icteric index be used instead of total bilirubin in addition to being a preanalytical marker? Icteric index in the laboratory
- 14 January 2025
- Published by Academician Publishing
- p. 81-92
Lipokinler
Lipokinler, adaptif termojenez ve enerji metabolizmasını düzenleyen lipit türevli hormonlardır. Bu moleküller, özellikle kahverengi ve bej yağ dokusunda enerji tüketimini artırarak obezite ve metabolik bozukluklarla mücadelede önemli terapötik hedefler sunmaktadır. Termojenik lipokinler arasında oleiletanolamin (OEA), prostaglandin E2 (PGE2) ve 12,13-diHOME gibi bileşikler yer alır. OEA, iştahı baskılayarak kilo kaybını teşvik ederken, PGE2 kahverengi yağ dokusu aktivitesini artırır. 12,13-diHOME ise yağ asitlerinin kas ve kahverengi yağ dokusuna alımını düzenler.Lipokinlerin etkileri, genellikle hücresel enzimler ve reseptörler aracılığıyla gerçekleşir. Örneğin, OEA, GPR119 ve PPAR gibi reseptörleri aktive ederken, PGE2 ve 12,13-diHOME'nin etkileri prostaglandin ve TRPV1 reseptörleri üzerinden gerçekleşir. Bununla birlikte, lipokinlerin hızlı metabolize edilmesi ve biyolojik çeşitlilikleri, terapötik uygulamalarını sınırlayan faktörlerdir.Bu moleküllerin biyosentez, yapısal özellikler ve yıkım süreçlerinin daha iyi anlaşılması, metabolik bozuklukların tedavisine yönelik yeni yaklaşımlar geliştirilmesini mümkün kılabilir. Lipokinlere yönelik araştırmalar, obezite ve ilişkili hastalıklara karşı umut vadeden çözümler sunmaktadır. Lipokines are lipid-derived hormones that regulate adaptive thermogenesis and energy metabolism. These molecules play a significant role in combating obesity and metabolic disorders by enhancing energy expenditure, particularly in brown and beige adipose tissues. Thermogenic lipokines include compounds such as oleoylethanolamide (OEA), prostaglandin E2 (PGE2), and 12,13-diHOME. OEA promotes weight loss by suppressing appetite, while PGE2 increases brown adipose tissue activity. 12,13-diHOME, on the other hand, regulates the uptake of fatty acids into muscles and brown adipose tissue.The effects of lipokines are mediated primarily through cellular enzymes and receptors. For instance, OEA activates receptors such as GPR119 and PPAR, whereas the effects of PGE2 and 12,13-diHOME are mediated through prostaglandin and TRPV1 receptors. However, the rapid metabolism and biological diversity of lipokines pose challenges to their therapeutic applications.A deeper understanding of the biosynthesis, structural properties, and degradation processes of these molecules could facilitate the development of novel approaches to treat metabolic disorders. Research on lipokines offers promising solutions for addressing obesity and related diseases.
- 14 January 2025
- Published by Academician Publishing
- p. 81-92
Lipokinler
Lipokinler, adaptif termojenez ve enerji metabolizmasını düzenleyen lipit türevli hormonlardır. Bu moleküller, özellikle kahverengi ve bej yağ dokusunda enerji tüketimini artırarak obezite ve metabolik bozukluklarla mücadelede önemli terapötik hedefler sunmaktadır. Termojenik lipokinler arasında oleiletanolamin (OEA), prostaglandin E2 (PGE2) ve 12,13-diHOME gibi bileşikler yer alır. OEA, iştahı baskılayarak kilo kaybını teşvik ederken, PGE2 kahverengi yağ dokusu aktivitesini artırır. 12,13-diHOME ise yağ asitlerinin kas ve kahverengi yağ dokusuna alımını düzenler.Lipokinlerin etkileri, genellikle hücresel enzimler ve reseptörler aracılığıyla gerçekleşir. Örneğin, OEA, GPR119 ve PPAR gibi reseptörleri aktive ederken, PGE2 ve 12,13-diHOME'nin etkileri prostaglandin ve TRPV1 reseptörleri üzerinden gerçekleşir. Bununla birlikte, lipokinlerin hızlı metabolize edilmesi ve biyolojik çeşitlilikleri, terapötik uygulamalarını sınırlayan faktörlerdir.Bu moleküllerin biyosentez, yapısal özellikler ve yıkım süreçlerinin daha iyi anlaşılması, metabolik bozuklukların tedavisine yönelik yeni yaklaşımlar geliştirilmesini mümkün kılabilir. Lipokinlere yönelik araştırmalar, obezite ve ilişkili hastalıklara karşı umut vadeden çözümler sunmaktadır. Lipokines are lipid-derived hormones that regulate adaptive thermogenesis and energy metabolism. These molecules play a significant role in combating obesity and metabolic disorders by enhancing energy expenditure, particularly in brown and beige adipose tissues. Thermogenic lipokines include compounds such as oleoylethanolamide (OEA), prostaglandin E2 (PGE2), and 12,13-diHOME. OEA promotes weight loss by suppressing appetite, while PGE2 increases brown adipose tissue activity. 12,13-diHOME, on the other hand, regulates the uptake of fatty acids into muscles and brown adipose tissue.The effects of lipokines are mediated primarily through cellular enzymes and receptors. For instance, OEA activates receptors such as GPR119 and PPAR, whereas the effects of PGE2 and 12,13-diHOME are mediated through prostaglandin and TRPV1 receptors. However, the rapid metabolism and biological diversity of lipokines pose challenges to their therapeutic applications.A deeper understanding of the biosynthesis, structural properties, and degradation processes of these molecules could facilitate the development of novel approaches to treat metabolic disorders. Research on lipokines offers promising solutions for addressing obesity and related diseases.
- Open Access
- 14 January 2025
- Published by Academician Publishing
Güncel Biyokimya Çalışmaları VIII
Kardiyovasküler Hastalık Risk Hesaplama Sistemleri ve Yeni Bir Model: Prevent Makbule Beyza ŞEN Yasemin ATICI Doğan YÜCEL Tek Karbon Metabolizmasında Vitamin B12 ve Folatın Rolü Ayşenur MACUN AYAN Klinik Laboratuvarlar İçin Metot Verifikasyonu Levent DENİZ Lipoprotein (a): Kardiyovasküler Risk Değerlendirmesinde Kritik Bir Lipoprotein Zeynep Mine YALÇINKAYA KARA Parkinson, Alzheimer ve ALS Gibi Hastalıklarda Mitokondriyal Fonksiyon Bozukluklarının Enerji Üretimindeki Aksamaları Naci Ömer ALAYUNT İnterlökin-22 ve Klinik Önemi Arzu YÜKSEL Lipokinler Merve Sena ODABAŞI Sarı Kantaronun İnsan Sağlığına Etkisi ve Tıp Alanında Kullanım Potansiyeli Murat ÇAKIR Kültür Eti Üretimi ve Özellikleri Adile Merve BAKI
- 14 January 2025
- Published by Academician Publishing
Open AccessGüncel Biyokimya Çalışmaları VIII
Kardiyovasküler Hastalık Risk Hesaplama Sistemleri ve Yeni Bir Model: Prevent Makbule Beyza ŞEN Yasemin ATICI Doğan YÜCEL Tek Karbon Metabolizmasında Vitamin B12 ve Folatın Rolü Ayşenur MACUN AYAN Klinik Laboratuvarlar İçin Metot Verifikasyonu Levent DENİZ Lipoprotein (a): Kardiyovasküler Risk Değerlendirmesinde Kritik Bir Lipoprotein Zeynep Mine YALÇINKAYA KARA Parkinson, Alzheimer ve ALS Gibi Hastalıklarda Mitokondriyal Fonksiyon Bozukluklarının Enerji Üretimindeki Aksamaları Naci Ömer ALAYUNT İnterlökin-22 ve Klinik Önemi Arzu YÜKSEL Lipokinler Merve Sena ODABAŞI Sarı Kantaronun İnsan Sağlığına Etkisi ve Tıp Alanında Kullanım Potansiyeli Murat ÇAKIR Kültür Eti Üretimi ve Özellikleri Adile Merve BAKI
- Open Access
- 9 May 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (2) , 145-151
Analysis of inappropriate repeated laboratory testing
Objectives: Laboratory services are an important part of the healthcare system. However many requested tests may be considered inappropriate or unnecessary. We evaluated laboratory use in a period of 3 years in terms of the inappropriate test repeats. Methods: We analyzed inappropriate repeat rate (IRR) of hemoglobin A1c (HbA1c), 25-OH vitamin D [25(OH)D], thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), anti-thyroid peroxidase antibody (anti-TPO), vitamin B12, folate, iron, ferritin and total cholesterol in the light of clinical guidelines. Results: IRR of 3 year was found to be 10% on average (4.2–15.5%). In TSH, FT3, and FT4 parameters, IRR was between 4.2 and 5.3%, while it was between 12.9 and 15.5% for 25(OH)D, iron, ferritin, and total cholesterol. In all tests (except anti-TPO), IRRs were found to be higher in inpatients for each of the 3 years. Inappropriate repetition of total cholesterol, iron, and ferritin parameters were more frequent in men. Inappropriate repeats were performed in all parameters (except HbA1c) after a result that had been in the reference range. Conclusions: Examined test repetitions were mostly inappropriate. To reduce the inappropriate laboratory test requests, it is important to analyze the causes and to ensure cooperation between laboratory specialists and clinicians.
- 9 May 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (2) , 145-151
Open AccessAnalysis of inappropriate repeated laboratory testing
Objectives: Laboratory services are an important part of the healthcare system. However many requested tests may be considered inappropriate or unnecessary. We evaluated laboratory use in a period of 3 years in terms of the inappropriate test repeats. Methods: We analyzed inappropriate repeat rate (IRR) of hemoglobin A1c (HbA1c), 25-OH vitamin D [25(OH)D], thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), anti-thyroid peroxidase antibody (anti-TPO), vitamin B12, folate, iron, ferritin and total cholesterol in the light of clinical guidelines. Results: IRR of 3 year was found to be 10% on average (4.2–15.5%). In TSH, FT3, and FT4 parameters, IRR was between 4.2 and 5.3%, while it was between 12.9 and 15.5% for 25(OH)D, iron, ferritin, and total cholesterol. In all tests (except anti-TPO), IRRs were found to be higher in inpatients for each of the 3 years. Inappropriate repetition of total cholesterol, iron, and ferritin parameters were more frequent in men. Inappropriate repeats were performed in all parameters (except HbA1c) after a result that had been in the reference range. Conclusions: Examined test repetitions were mostly inappropriate. To reduce the inappropriate laboratory test requests, it is important to analyze the causes and to ensure cooperation between laboratory specialists and clinicians.
- 7 February 2021
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 43 (S1) , 142-151
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19
Introduction: Studies have shown that iron metabolism is affected by coronavirus disease 19 (COVID‐19), which has spread worldwide and has become a global health problem. Our study aimed to evaluate the relationship between COVID‐19 and serum erythropoietin (EPO), hepcidin, and haptoglobin (Hpt) levels with disease severity, and other biochemical values.Methods: Fifty nine COVID‐19 patients hospitalized in the intensive care unit (ICU) and wards in our hospital between March and June 2020 and 19 healthy volunteers were included in the study. Participants were divided into mild, severe, and critical disease severity groups. Group mean values were analyzed with SPSS according to disease severity, mortality, and intubation status.Results: Hemoglobin (Hb) levels were significantly lower in the critical patient group (P < .0001) and deceased group (P < .0001). The red blood cell distribution width‐coefficient of variation (RDW‐CV) and ferritin values were significantly higher in the intubated (P = .001, P = .005) and deceased (P = .014, P = .003) groups. Ferritin values were positively correlated with disease severity (P < .0001). Serum iron levels were lower in the patient group compared with the reference range. (P < .0001). It was found that the transferrin saturation (TfSat) was lower in the patient group compared with the control group (P < .0001). It was found that the mean EPO of the deceased was lower than the control group and the survived patient group (P = .035). Hepcidin levels were found to be significantly lower in the patient group (P < .0001). Hpt values were found to be significantly lower in the intubated group (P = .004) and the deceased group (P = .042).Conclusion: In our study, while serum iron and hepcidin levels decreased in patients diagnosed with COVID‐19, we found that EPO and Hpt levels were significantly lower in critical and deceased patient groups. Our study is the first study examining EPO and Hpt levels in patients diagnosed with COVID‐19.
- 7 February 2021
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 43 (S1) , 142-151
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19
Introduction: Studies have shown that iron metabolism is affected by coronavirus disease 19 (COVID‐19), which has spread worldwide and has become a global health problem. Our study aimed to evaluate the relationship between COVID‐19 and serum erythropoietin (EPO), hepcidin, and haptoglobin (Hpt) levels with disease severity, and other biochemical values.Methods: Fifty nine COVID‐19 patients hospitalized in the intensive care unit (ICU) and wards in our hospital between March and June 2020 and 19 healthy volunteers were included in the study. Participants were divided into mild, severe, and critical disease severity groups. Group mean values were analyzed with SPSS according to disease severity, mortality, and intubation status.Results: Hemoglobin (Hb) levels were significantly lower in the critical patient group (P < .0001) and deceased group (P < .0001). The red blood cell distribution width‐coefficient of variation (RDW‐CV) and ferritin values were significantly higher in the intubated (P = .001, P = .005) and deceased (P = .014, P = .003) groups. Ferritin values were positively correlated with disease severity (P < .0001). Serum iron levels were lower in the patient group compared with the reference range. (P < .0001). It was found that the transferrin saturation (TfSat) was lower in the patient group compared with the control group (P < .0001). It was found that the mean EPO of the deceased was lower than the control group and the survived patient group (P = .035). Hepcidin levels were found to be significantly lower in the patient group (P < .0001). Hpt values were found to be significantly lower in the intubated group (P = .004) and the deceased group (P = .042).Conclusion: In our study, while serum iron and hepcidin levels decreased in patients diagnosed with COVID‐19, we found that EPO and Hpt levels were significantly lower in critical and deceased patient groups. Our study is the first study examining EPO and Hpt levels in patients diagnosed with COVID‐19.
- 15 October 2019
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 45 (1) , 19-25
Impact of preventive actions on rejection rates in the preanalytical period
Background: It is responsibility of medical laboratories to determine and reject nonconforming samples as well as take preventive actions. In this study, we examined reasons and percentages of rejected samples. We also investigated impact of the preventive actions on decreasing the rejection rates. Materials and methods: Reasons for rejection were determined by Pareto analysis. Sigma analysis was used for each month to evaluate the ratios and compare with other studies. Some preventive actions were taken to reduce the rejection rates. Pearson’s chi square test was used to evaluate effects of preventive actions. Significance level was determined as p < 0.05. Results: Most of the rejected samples consisted of samples not received by the laboratory, haemolysed and insufficient samples. The percentages of samples not received by the laboratory and insufficient samples were reduced from 3.80% to 1.94% and 0.33% to 0.31% respectively, while haemolysed samples percentage was increased from 2.83% to 3.37% after the improvement actions. Also, sigma levels for samples not received by the laboratory and haemolysed samples were at the minimum while insufficient samples were at a reasonable level. Conclusion: Improvement actions achieved statistically significant decreases for samples not received by the laboratories for a long-term.
- 15 October 2019
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 45 (1) , 19-25
Impact of preventive actions on rejection rates in the preanalytical period
Background: It is responsibility of medical laboratories to determine and reject nonconforming samples as well as take preventive actions. In this study, we examined reasons and percentages of rejected samples. We also investigated impact of the preventive actions on decreasing the rejection rates. Materials and methods: Reasons for rejection were determined by Pareto analysis. Sigma analysis was used for each month to evaluate the ratios and compare with other studies. Some preventive actions were taken to reduce the rejection rates. Pearson’s chi square test was used to evaluate effects of preventive actions. Significance level was determined as p < 0.05. Results: Most of the rejected samples consisted of samples not received by the laboratory, haemolysed and insufficient samples. The percentages of samples not received by the laboratory and insufficient samples were reduced from 3.80% to 1.94% and 0.33% to 0.31% respectively, while haemolysed samples percentage was increased from 2.83% to 3.37% after the improvement actions. Also, sigma levels for samples not received by the laboratory and haemolysed samples were at the minimum while insufficient samples were at a reasonable level. Conclusion: Improvement actions achieved statistically significant decreases for samples not received by the laboratories for a long-term.